Online citations, reference lists, and bibliographies.

A Cost-Utility Analysis Of Alternative Strategies In Screening For Breast Cancer

G. Parmigiani, M. Kamlet
Published 1993 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Screening for early detection is a primary way to control breast cancer. The choice of effective screening policies involves substantial uncertainty and difficult tradeoffs among medical costs and the duration and quality of life. In this paper, we study the choice of the age at which screening should begin and the frequency of screening tests. These have been issues of important debate in the health policy community. We address these questions using the framework of cost-utility analysis, as we consider it important to evaluate the outcomes of preventive care in terms of morbidity and quality of life, in addition to survival. After a brief review of background information on breast cancer screening, we introduce cost-utility analysis and its relation with Bayesian decision-making. We then discuss modelling and prior specifications, and carry out a cost-utility evaluation of the currently recommended policy. Finally we compare those to the the Bayes-optimal decision for various values of the exchange rate between dollars and quality of life. We discuss the implications of the results for actual policy decisions.
This paper references
10.1177/0272989X8300300111
A Mathematical Model for Timing Repeated Medical Tests
D. Eddy (1983)
Understanding Health Eco- nomics
J. F. Rapopart (1982)
Optimal Scheduling of Medical Exams: the Case of Breast Can- cer," ISDS, Duke University, Discussion Paper 91-A16
G. Parmigiani (1991)
10.1001/jama.1988.03720100030034
The value of mammography screening in women under age 50 years.
D. Eddy (1988)
A Framework for Cost-Utility Analysis of Government Health Care Programs. U.S. Department of Health and Human Services, Washington
M S.Kamlet (1991)
Age-Speci c Reduction in Breast Cancer Mortality by Screening" JNCI
D FHabbemaJ. (1986)
Mathematical Models in Screening," Cancer Epi- demiology and Prevention (D
D M.M.Eddy (1982)
10.1056/NEJM199101173240305
Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model.
B. Hillner (1991)
10.1016/0025-5564(78)90076-7
Screening for the early detection of cancer— III. Estimation of disease natural history
T. Louis (1978)
10.1080/01621459.1993.10476315
On Optimal Screening Ages
G. Parmigiani (1993)
10.1148/radiology.161.1.3532183
Breast cancer: age-specific growth rates and screening strategies.
M. Moskowitz (1986)
Clinical Decision Analysis Saunders, Philadelphia
C WeinsteinM. (1980)
10.3322/canjclin.40.1.9
Cancer statistics, 1990
E. Silverberg (1990)
10.1097/00000658-198809000-00010
Economic Impact of Reducing Hospitalization for Mastectomy Patients
M. Edwards (1988)
10.1002/1097-0142(197405)33:5<1444::AID-CNCR2820330530>3.0.CO;2-B
Examination schedules for breast cancer
R. Kirch (1974)
10.1287/opre.28.1.206
Utility Functions for Life Years and Health Status
J. Pliskin (1980)
Mammographic Screening in Asymptomatic Women Aged 40 Years and Older," J.A.M.A
M A.A. (1989)
10.1016/S0749-3797(18)30967-X
Is routine mammography screening appropriate for women 40-49 years of age?
A. Miller (1991)
10.1093/biomet/80.2.279
Optimal scheduling of examinations for the early detection of disease
M. Zelen (1993)
10.1016/0021-9681(81)90026-6
Concepts and problems in the evaluation of screening programs.
P. Prorok (1981)
10.1093/oxfordjournals.aje.a113705
Estimation of the duration of a pre-clinical disease state using screening data.
S. Walter (1983)
10.1016/0021-9681(78)90072-3
The utility of different health states as perceived by the general public.
D. Sackett (1978)
10.7326/0003-4819-109-7-603_1
The Medical Management Of Breast Cancer
C. J. Williams (1987)
10.1056/NEJM197703312961304
Foundations of cost-effectiveness analysis for health and medical practices.
M. Weinstein (1977)
Optimal Scheduling of Medical Exams: the Case of Breast Can- cer," ISDS, Duke University, Discussion Paper 91-A16
G. Parmigiani (1991)
10.1002/ijc.2910490411
The impact of a breast cancer screening programme on quality‐adjusted life‐years
J. de Haes (1991)
Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening.
J. S. Spratt (1986)
Thronbury: (1991) \The E cacy of Diagnostic Imaging,
S. C. Fryback (1991)
10.1002/sim.4780050204
Case-control studies for estimation of the natural history of preclinical disease from screening data.
R. Brookmeyer (1986)



This paper is referenced by
10.3310/HTA4380
Bayesian methods in health technology assessment: a review.
D. Spiegelhalter (2000)
10.1007/978-1-4612-1284-3_7
The Use of Reference Priors and Bayes Factors in the Analysis of Clinical Trials
D. Stangl (2000)
10.1177/0272989X14528380
The Influence of Disease Risk on the Optimal Time Interval between Screens for the Early Detection of Cancer
James F. O’Mahony (2015)
10.1007/0-387-26023-4_27
Optimization of Breast Cancer Screening Modalities
Y. Shen (2006)
10.21236/ada407384
Individualized Strategies for Breast Cancer Surveillance Based on Aggregated Familial Information
A. Yakovlev (2002)
10.1080/01621459.1996.10476993
The Equivalence of Constrained and Weighted Designs in Multiple Objective Design Problems
M. Clyde (1996)
10.1016/j.ijar.2008.03.017
Bayesian robustness for decision making problems: Applications in medical contexts
J. Martín (2009)
10.1007/978-3-662-12516-8_4
Simulation Approach to One-Stage and Sequential Optimal Design Problems
G. Parmigiani (1995)
10.1198/tech.2005.s851
Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation
D. Spieǵelhalter (2004)
10.1080/01621459.1995.10476636
Optimal Design via Curve Fitting of Monte Carlo Experiments
P. Müller (1995)
10.1016/S0895-7177(01)80023-6
Optimal schedules of cancer surveillance and tumor size at detection
L. Hanin (2001)
10.1158/1055-9965.EPI-04-0499
A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations
Y. Shen (2005)
10.1093/BIOMET/84.4.803
Timing medical examinations via intensity functions
G. Parmigiani (1997)
10.1002/0470092602
Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation
D. Spiegelhalter (2004)
10.1214/ss/1177009939
Bayesian Experimental Design: A Review
Kathryn Chaloner (1995)
Semantic Scholar Logo Some data provided by SemanticScholar